Your browser doesn't support javascript.
loading
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Wall, Emma C; Wu, Mary; Harvey, Ruth; Kelly, Gavin; Warchal, Scott; Sawyer, Chelsea; Daniels, Rodney; Hobson, Philip; Hatipoglu, Emine; Ngai, Yenting; Hussain, Saira; Nicod, Jerome; Goldstone, Robert; Ambrose, Karen; Hindmarsh, Steve; Beale, Rupert; Riddell, Andrew; Gamblin, Steve; Howell, Michael; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Bauer, David Lv.
Afiliação
  • Wall EC; Francis Crick Institute, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
  • Wu M; Francis Crick Institute, London, UK.
  • Harvey R; Francis Crick Institute, London, UK.
  • Kelly G; Francis Crick Institute, London, UK.
  • Warchal S; Francis Crick Institute, London, UK.
  • Sawyer C; Francis Crick Institute, London, UK.
  • Daniels R; Francis Crick Institute, London, UK.
  • Hobson P; Francis Crick Institute, London, UK.
  • Hatipoglu E; University College London, London, UK.
  • Ngai Y; University College London, London, UK.
  • Hussain S; Francis Crick Institute, London, UK.
  • Nicod J; Francis Crick Institute, London, UK.
  • Goldstone R; Francis Crick Institute, London, UK.
  • Ambrose K; Francis Crick Institute, London, UK.
  • Hindmarsh S; Francis Crick Institute, London, UK.
  • Beale R; Francis Crick Institute, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
  • Riddell A; Francis Crick Institute, London, UK.
  • Gamblin S; Francis Crick Institute, London, UK.
  • Howell M; Francis Crick Institute, London, UK.
  • Kassiotis G; Francis Crick Institute, London, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Swanton C; Francis Crick Institute, London, UK.
  • Gandhi S; Francis Crick Institute, London, UK; University College London, London, UK.
  • Bauer DL; Francis Crick Institute, London, UK. Electronic address: david.bauer@crick.ac.uk.
Lancet ; 397(10292): 2331-2333, 2021 06 19.
Article em En | MEDLINE | ID: mdl-34090624
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / Anticorpos Antivirais Limite: Adult / Humans / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / Anticorpos Antivirais Limite: Adult / Humans / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article